Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients (NAPLESIII)

This study has been completed.
Information provided by (Responsible Party):
Carlo Briguori, Clinica Mediterranea Identifier:
First received: November 1, 2011
Last updated: April 6, 2014
Last verified: April 2014